Weight and plasma lipid control by decaffeinated green tea

Pharmacological Research

Volumn 59, Issue 5, 2009, Pages 351-354

  Richard, Doriane ^a   Kefi, Kaouthar ^a   Barbe, Ullah ^a   Poli, Andrea ^b   Bausero, Pedro ^a   Visioli, Francesco ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b Nutrition Foundation of Italy   (Italy)

Author keywords

Decaffeinated; Diet; Green tea; Obesity; Polyphenols

Indexed keywords

ADIPONECTIN; BUFFER; CATECHIN; CHOLESTEROL; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FECES LIPID; FLAVONOID; GALLOCATECHIN; GALLOCATECHIN GALLATE; HEPARIN; LIPID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; BODY WEIGHT; CONTROLLED STUDY; FLUID INTAKE; HEART; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; TEA; WEIGHT GAIN;

ADIPONECTIN; ANIMALS; ANTI-OBESITY AGENTS; ANTILIPEMIC AGENTS; CAFFEINE; CATECHIN; CHOLESTEROL; FECES; HYPERLIPIDEMIAS; LEPTIN; LIPID METABOLISM; LIPIDS; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; PLANT PREPARATIONS; TEA; TRIGLYCERIDES; WEIGHT GAIN;

EID: 63549129320     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2009.01.015     Document Type: Article

References (32)

1. World Health Organization. Obesity: preventing and managing the global epidemic. WHO Technical Report Series No. 894; 2000. Geneva: WHO.
2. James W.P. The epidemiology of obesity: the size of the problem. J Int Med 263 (2008) 336-352
3. Mathers C.D., and Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3 (2006) e442
4. Galani C., and Schneider H. Prevention and treatment of obesity with lifestyle interventions: review and meta-analysis. Int J Public Health 52 (2007) 348-359
5. Visioli F., Poli A., Peracino A., Luzi L., Cannella C., and Paoletti R. Assessment of nutritional profiles: a novel system based on a comprehensive approach. Br J Nutr 98 (2007) 1101-1107
6. Deitel M. The international obesity task force and "globesity". Obes Surg 12 (2002) 613-614
7. WHO, Globalization, diets and noncommunicable diseases; 2002.
8. Visioli F., and Hagen T.M. Nutritional strategies for healthy cardiovascular aging: focus on micronutrients. Pharmacol Res 55 (2007) 199-206
9. Wolfram S., Wang Y., and Thielecke F. Anti-obesity effects of green tea: from bedside to bench. Mol Nutr Food Res 50 (2006) 176-187
10. Babu P.V., Sabitha K.E., Srinivasan P., and Shyamaladevi C.S. Green tea attenuates diabetes induced Maillard-type fluorescence and collagen cross-linking in the heart of streptozotocin diabetic rats. Pharmacol Res 55 (2007) 433-440
11. Jin J.Y., Park S.H., Bae J.H., Cho H.C., Lim J.G., Park W.S., et al. Uncoupling by (-)-epigallocatechin-3-gallate of ATP-sensitive potassium channels from phosphatidylinositol polyphosphates and ATP. Pharmacol Res 56 (2007) 237-247
12. Carter O., Dashwood R.H., Wang R., Dashwood W.M., Orner G.A., Fischer K.A., et al. Comparison of white tea, green tea, epigallocatechin-3-gallate, and caffeine as inhibitors of PhIP-induced colonic aberrant crypts. Nutr Cancer 58 (2007) 60-65
13. Wang R., Dashwood W.M., Lohr C.V., Fischer K.A., Pereira C.B., Louderback M., et al. Protective versus promotional effects of white tea and caffeine on PhIP-induced tumorigenesis and beta-catenin expression in the rat. Carcinogenesis 29 (2008) 834-839
14. Folch J., Lees M., and SloaneStanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226 (1957) 497-509
15. Giannessi D., Maltinti M., and DelRy S. Adiponectin circulating levels: a new emerging biomarker of cardiovascular risk. Pharmacol Res 56 (2007) 459-467
16. Bruno R.S., Dugan C.E., Smyth J.A., DiNatale D.A., and Koo S.I. Green tea extract protects leptin-deficient, spontaneously obese mice from hepatic steatosis and injury. J Nutr 138 (2008) 323-331
17. Delporte M.L., El Mkadem S.A., Quisquater M., and Brichard S.M. Leptin treatment markedly increased plasma adiponectin but barely decreased plasma resistin of ob/ob mice. Am J Physiol Endocrinol Metab 287 (2004) E446-E453
18. Lin J.K., and Lin-Shiau S.Y. Mechanisms of hypolipidemic and anti-obesity effects of tea and tea polyphenols. Mol Nutr Food Res 50 (2006) 211-217
19. Nagao T., Komine Y., Soga S., Meguro S., Hase T., Tanaka Y., et al. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am J Clin Nutr 81 (2005) 122-129
20. Auvichayapat P., Prapochanung M., Tunkamnerdthai O., Sripanidkulchai B.O., Auvichayapat N., Thinkhamrop B., et al. Effectiveness of green tea on weight reduction in obese Thais: a randomized, controlled trial. Physiol Behav 93 (2008) 486-491
21. Dulloo A.G., Duret C., Rohrer D., Girardier L., Mensi N., Fathi M., et al. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr 70 (1999) 1040-1045
22. Dulloo A.G., Seydoux J., Girardier L., Chantre P., and Vandermander J. Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. Int J Obes Relat Metab Disord 24 (2000) 252-258
23. Choo J.J. Green tea reduces body fat accretion caused by high-fat diet in rats through beta-adrenoceptor activation of thermogenesis in brown adipose tissue. J Nutr Biochem 14 (2003) 671-676
24. Furuyashiki T., Nagayasu H., Aoki Y., Bessho H., Hashimoto T., Kanazawa K., et al. Tea catechin suppresses adipocyte differentiation accompanied by down-regulation of PPARgamma2 and C/EBPalpha in 3T3-L1 cells. Biosci Biotechnol Biochem 68 (2004) 2353-2359
25. Shishikura Y., Khokhar S., and Murray B.S. Effects of tea polyphenols on emulsification of olive oil in a small intestine model system. J Agric Food Chem 54 (2006) 1906-1913
26. Raederstorff D.G., Schlachter M.F., Elste V., and Weber P. Effect of EGCG on lipid absorption and plasma lipid levels in rats. J Nutr Biochem 14 (2003) 326-332
27. Hsu T.F., Kusumoto A., Abe K., Hosoda K., Kiso Y., Wang M.F., et al. Polyphenol-enriched oolong tea increases fecal lipid excretion. Eur J Clin Nutr 60 (2006) 1330-1336
28. Bose M., Lambert J.D., Ju J., Reuhl K.R., Shapses S.A., and Yang C.S. The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J Nutr 138 (2008) 1677-1683
29. Koo M.W., and Cho C.H. Pharmacological effects of green tea on the gastrointestinal system. Eur J Pharmacol 500 (2004) 177-185
30. Koo S.I., and Noh S.K. Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect. J Nutr Biochem 18 (2007) 179-183
31. Fiorini R.N., Donovan J.L., Rodwell D., Evans Z., Cheng G., May H.D., et al. Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice. Liver Transpl 11 (2005) 298-308
32. Kao Y.H., Hiipakka R.A., and Liao S. Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology 141 (2000) 980-987